A novel two-stage approach to the treatment of renal cell carcinoma with intra-cardiac tumour extension and Budd-Chiari syndrome

BJU Int. 2024 Apr;133(4):480-486. doi: 10.1111/bju.16257. Epub 2023 Dec 26.

Abstract

Objective: To present the early results of a new technique for the treatment of renal cell carcinoma with intra-cardiac tumour extension and Budd-Chiari syndrome.

Patients and methods: The first stage involves transdiaphragmatic debulking of the right heart, inferior vena cava (IVC) and hepatic veins via median sternotomy, followed by a purse-string suture placed in the IVC below the hepatic veins. The second stage is performed separately and involves en bloc resection of the affected kidney, and IVC and vascular reconstruction via an abdominal incision.

Results: Three of five patients presented with clinical Budd-Chiari syndrome; two had radiological features only. The median time between surgical procedures was 12 days (IQR 13 days). Four of the five patients had a R0 resection. While all five patients successfully completed both operative stages, one patient died 22 days after the second stage. Of the remaining four, all survive with no disease recurrence.

Conclusion: While we continue to compile longer-term data for a larger follow-up series, these preliminary findings show the feasibility of this technique and support the development of this programme of surgery.

Keywords: Budd-Chiari; deep hypothermic circulatory arrest; hepatic veins; inferior vena cava graft; liver cold perfusion; liver failure; renal cell carcinoma; surgical technique; survival; tumour thrombus.

MeSH terms

  • Budd-Chiari Syndrome* / pathology
  • Budd-Chiari Syndrome* / surgery
  • Carcinoma, Renal Cell* / surgery
  • Heart Neoplasms*
  • Humans
  • Kidney Neoplasms* / surgery
  • Neoplasm Recurrence, Local
  • Vena Cava, Inferior / pathology
  • Vena Cava, Inferior / surgery